GLP Research
Research documentation for GLP-1 receptor agonist compounds. All content is for laboratory and scientific research purposes only.
What Is Semaglutide? Research Overview of the GLP-1 Receptor Agonist Peptide
An educational overview of semaglutide's peptide structure and GLP-1 receptor mechanism for laboratory and preclinical research contexts.
Tirzepatide vs Semaglutide: Receptor Mechanisms and Research Differences
A mechanistic comparison of tirzepatide (dual GLP-1/GIP agonist) and semaglutide (selective GLP-1 agonist), including structural differences, receptor selectivity, and considerations for research applications.
Retatrutide vs Tirzepatide: A Comparative Research Overview
A detailed comparison of retatrutide (GLP-1/GIP/glucagon triple agonist) and tirzepatide (GLP-1/GIP dual agonist) mechanisms, receptor profiles, and research applications.
What Is Tirzepatide? Dual GIP/GLP-1 Receptor Agonist Research Overview
Tirzepatide is a synthetic dual agonist peptide targeting GIP and GLP-1 receptors, with an extended plasma half-life enabled by a fatty acid conjugation strategy.
What Is Retatrutide? A Researcher's Overview of the Triple Agonist Peptide
Retatrutide is a once-weekly injectable triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, under investigation for metabolic research applications.
